Ventrus Biosciences (VTUS)

Add to Watchlists Create an Alert
2.66 -0.10  -3.62%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Ventrus Biosciences SG&A Expense Quarterly:

1.075M for Dec. 31, 2012
View Full Chart

Ventrus Biosciences SG&A Expense Quarterly Chart

    Ventrus Biosciences Historical SG&A Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 1.075M
    Sept. 30, 2012 1.182M
    June 30, 2012 1.316M
    March 31, 2012 1.767M
    Dec. 31, 2011 1.348M
    Sept. 30, 2011 1.879M
    June 30, 2011 3.802M
    March 31, 2011 1.696M
       
    Dec. 31, 2010 2.423M
    Sept. 30, 2010 0.3171M
    June 30, 2010 0.1387M
    March 31, 2010 0.0365M
    Dec. 31, 2009 0.1856M
    Sept. 30, 2009 0.0401M
    June 30, 2009 0.0185M
    March 31, 2009 0.1531M

    About SG&A Expense

    SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

    The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
    Learn More

    Get data for

    VTUS SG&A Expense Quarterly Benchmarks

    Companies
    GlaxoSmithKline 3.161B
    Herbalife 728.75M
    Siga Technologies 3.377M

    VTUS SG&A Expense Quarterly Rankings

    Overall 39th percentile
    4577 of 7600
    Sector 16th percentile
    545 of 653 in Healthcare
    Industry 20th percentile
    42 of 53 in Drug Manufacturers - Major

    VTUS SG&A Expense Quarterly Range, Past 5 Years

    Minimum 0.0185M Jun 2009
    Maximum 3.802M Jun 2011
    Average 1.086M

    VTUS News